Three Month Follow-Up of Patients With COVID-19 Pneumonia Complicated by Pulmonary Embolism

被引:7
|
作者
Calabrese, Cecilia [1 ]
Annunziata, Anna [2 ]
Flora, Martina [2 ]
Mariniello, Domenica Francesca [1 ]
Allocca, Valentino [1 ]
Palma, Maria Ilaria [1 ]
Coppola, Antonietta [2 ]
Meoli, Ilernando [2 ]
Pafundi, Pia Clara [3 ]
Fiorentino, Giuseppe [2 ]
机构
[1] Univ Campania Luigi Vanvitelli, Dept Translat Med Sci, Naples, Italy
[2] AORN Colli, Dept Intens Care, Naples, Italy
[3] Fdn Policlin Gemelli, GEMELLI GENERATOR, Facil Epidemiol & Biostat, Rome, Italy
关键词
COVID; 19; pulmonary embolism; lung function; spirometry; DLCO; KCO; six minute walk test; THORACIC SOCIETY; SPIROMETRY;
D O I
10.3389/fmolb.2021.809186
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background: Previous studies have demonstrated persistent dyspnoea and impairment of respiratory function in the follow-up of patients who have recovered from COVID-19 pneumonia. However, no studies have evaluated the clinical and functional consequences of COVID-19 pneumonia complicated by pulmonary embolism.Objective: The aim of our study was to assess the pulmonary function and exercise capacity in COVID-19 patients 3 months after recovery from pneumonia, either complicated or not by pulmonary embolism.Methods: This was a retrospective, single-centre, observational study involving 68 adult COVID-19 patients with a positive/negative clinical history of pulmonary embolism (PE) as a complication of COVID-19 pneumonia. Three months after recovery all patients underwent spirometry, diffusion capacity of the lungs for carbon monoxide (DLCO), and 6 minute walk test (6MWT). In addition, high-resolution computed tomography (HRCT) of the lung was carried out and CT-pulmonary angiography was conducted only in the PE+ subgroup. Patients with a previous diagnosis of PE or chronic lung diseases were excluded from the study.Results: Of the 68 patients included in the study, 24 had previous PE (PE+) and 44 did not (PE-). In comparison with the PE- subgroup, PE+ patients displayed a FVC% predicted significantly lower (87.71 +/- 15.40 vs 98.7 +/- 16.7, p = 0.009) and a significantly lower DLCO% predicted (p = 0.023). In addition, a higher percentage of patients were dyspnoeic on exercise, as documented by a mMRC score >= 1 (75% vs 54.3%, p < 0.001) and displayed a SpO(2) <90% during 6MWT (37.5% vs 0%, p < 0.001). HRCT features suggestive of COVID-19 pneumonia resolution phase were present in both PE+ and PE- subjects without any significant difference (p = 0.24) and abnormalities at CT pulmonary angiography were detected in 57% of the PE+ subgroup.Conclusion: At the 3 month follow-up, the patients who recovered from COVID-19 pneumonia complicated by PE showed more dyspnoea and higher impairment of pulmonary function tests compared with those without PE.
引用
收藏
页数:7
相关论文
共 50 条
  • [41] Complications in COVID-19 patients: Characteristics of pulmonary embolism
    Cau, Riccardo
    Pacielli, Alberto
    Fatemeh, Homayounieh
    Vaudano, Paolo
    Arru, Chiara
    Crivelli, Paola
    Stranieri, Giuseppe
    Suri, Jasjit S.
    Mannelli, Lorenzo
    Conti, Maurizio
    Mahammedi, Abdelkader
    Kalra, Mannudeep
    Saba, Luca
    CLINICAL IMAGING, 2021, 77 : 244 - 249
  • [42] Pulmonary Embolism in Covid-19 Pandemic: A Threat to Recovery of the Infected Patients
    Obeagu, Emmanuel Ifeanyi
    Babar, Quratulain
    Vincent, C. C. N.
    Okafor, Chukwuma J.
    Eze, Richard
    Chijioke, Udunma Olive
    Ibekwe, Adaobi Maryann
    Uduchi, Immaculata Ogochukwu
    JOURNAL OF PHARMACEUTICAL RESEARCH INTERNATIONAL, 2021, 33 (42A) : 90 - 98
  • [43] Massive polyuria associated with severe COVID-19-related pneumonia complicated by pulmonary embolism
    Pertseva, Tetiana O.
    Kireyeva, Tetiana V.
    Dubyna, Volodymyr I.
    Kobelatskyy, Yuriy Y.
    Bardachenko, Lubov A.
    Gavva, Olena A.
    Semenov, Viktor V.
    Kuryata, Olexandr V.
    GAZZETTA MEDICA ITALIANA ARCHIVIO PER LE SCIENZE MEDICHE, 2022, 181 (11) : 904 - 906
  • [44] Echocardiographic assessment of pulmonary arterial pressure in the follow-up of patients with pulmonary embolism
    Otero, Remedios
    Oribe, Mikel
    Ballaz, Aitor
    Jimenez, David
    Uresandi, Fernando
    Nauffal, Dolores
    Conget, Francisco
    Rodriguez, Consolacion
    Elias, Teresa
    Jara, Luis
    Cayuela, Aurelio
    Blanco, Isabel
    Barbera, Joan
    THROMBOSIS RESEARCH, 2011, 127 (04) : 303 - 308
  • [45] Post-Covid Interstitial Lung Disease (PC-ILD): the role of pulmonary function testing and lung imaging in the long-term follow-up of patients with COVID-19 pneumonia
    Sanna, A.
    Pellegrino, D.
    Messina, E.
    Siena, L. M.
    Baccolini, V.
    D'Antoni, L.
    Baiocchi, P.
    Villari, P.
    Catalano, C.
    Panebianco, V.
    Palange, P.
    D'Antoni, L.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [46] Catheter-directed thrombolysis in a COVID-19 patient complicated with pulmonary embolism
    Kocas, Betul Balaban
    Kilickesmez, Kadriye
    TURKISH JOURNAL OF EMERGENCY MEDICINE, 2022, 22 (01): : 54 - 57
  • [47] Pulmonary Embolism: outpatient Treatment and Follow-up
    Hobohm, Lukas
    Keller, Karsten
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2024, 149 (20) : 1191 - 1199
  • [48] Importance of troponin T for the risk stratification of normotensive patients with pulmonary embolism. A prospective, cohort study with a three-month follow-up
    Bova, C
    Crocco, F
    Ricchio, R
    Serafini, O
    Greco, F
    Noto, A
    HAEMATOLOGICA, 2005, 90 (03) : 423 - 424
  • [49] Quantitative CT Texture Analysis of COVID-19 Hospitalized Patients during 3-24-Month Follow-Up and Correlation with Functional Parameters
    Fanni, Salvatore Claudio
    Volpi, Federica
    Colligiani, Leonardo
    Chimera, Davide
    Tonerini, Michele
    Pistelli, Francesco
    Pancani, Roberta
    Airoldi, Chiara
    Bartholmai, Brian J.
    Cioni, Dania
    Carrozzi, Laura
    Neri, Emanuele
    De Liperi, Annalisa
    Romei, Chiara
    DIAGNOSTICS, 2024, 14 (05)
  • [50] Three-month and six-month outcomes of patients with COVID-19 associated hyperinflammation treated with short-term immunosuppressive therapy: follow-up of the CHIC study
    Janssen, Marlou T. H. F.
    Ramiro, Sofia
    Mostard, Remy L. M.
    Magro-Checa, Cesar
    Landewe, Robert B. M.
    RMD OPEN, 2021, 7 (03):